Rahmig J, Chanpura A, Schultz A, Barone F, Gustafson D, Baird A
Front Neurol. 2024; 15:1411307.
PMID: 39091977
PMC: 11291248.
DOI: 10.3389/fneur.2024.1411307.
Carrillo Navarrete K, Chapa Gonzalez C
Ibrain. 2024; 10(1):59-68.
PMID: 38682021
PMC: 11045183.
DOI: 10.1002/ibra.12146.
Gendosz de Carrillo D, Kocikowska O, Rak M, Krzan A, Student S, Jedrzejowska-Szypulka H
Int J Mol Sci. 2024; 25(5).
PMID: 38474013
PMC: 10931570.
DOI: 10.3390/ijms25052766.
Conley H, Till R, Berglund A, Jones S, Sheats M
Cell Adh Migr. 2023; 17(1):1-16.
PMID: 37439125
PMC: 10348033.
DOI: 10.1080/19336918.2023.2233204.
Conley H, Sheats M
Biomolecules. 2023; 13(6).
PMID: 37371473
PMC: 10296028.
DOI: 10.3390/biom13060892.
Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration.
Hayes A, Farrugia B, Biose I, Bix G, Melrose J
Front Cell Dev Biol. 2022; 10:856261.
PMID: 35433700
PMC: 9010944.
DOI: 10.3389/fcell.2022.856261.
Tet Enzymes-Mediated DNA 5hmC Modification in Cerebral Ischemic and Hemorrhagic Injury.
Ma X, Yang B, Li X, Miao Z
Neurotox Res. 2022; 40(3):884-891.
PMID: 35394559
DOI: 10.1007/s12640-022-00505-7.
New Drug Targets to Prevent Death Due to Stroke: A Review Based on Results of Protein-Protein Interaction Network, Enrichment, and Annotation Analyses.
Maes M, Nikiforov N, Plaimas K, Suratanee A, Alfieri D, Reiche E
Int J Mol Sci. 2021; 22(22).
PMID: 34829993
PMC: 8619767.
DOI: 10.3390/ijms222212108.
Bioactive Flavonoids Icaritin and Icariin Protect against Cerebral Ischemia-Reperfusion-Associated Apoptosis and Extracellular Matrix Accumulation in an Ischemic Stroke Mouse Model.
Wu C, Chen M, Liu S, Yang T, Long L, Guan S
Biomedicines. 2021; 9(11).
PMID: 34829948
PMC: 8615444.
DOI: 10.3390/biomedicines9111719.
Negative Regulators of Inflammation Response to the Dynamic Expression of Cytokines in DF-1 and MDCK Cells Infected by Avian Influenza Viruses.
Zhao B, Li H, Cao S, Zhong W, Li B, Jia W
Inflammation. 2021; 45(2):573-589.
PMID: 34581936
DOI: 10.1007/s10753-021-01568-y.
Brain Immune Interactions-Novel Emerging Options to Treat Acute Ischemic Brain Injury.
Muhammad S, Chaudhry S, Kahlert U, Niemela M, Hanggi D
Cells. 2021; 10(9).
PMID: 34572077
PMC: 8472028.
DOI: 10.3390/cells10092429.
Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue.
Ponsaerts L, Alders L, Schepers M, de Oliveira R, Prickaerts J, Vanmierlo T
Biomedicines. 2021; 9(7).
PMID: 34206420
PMC: 8301462.
DOI: 10.3390/biomedicines9070703.
The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology.
Lamers C, Pluss C, Ricklin D
Front Immunol. 2021; 12:662164.
PMID: 33995387
PMC: 8118671.
DOI: 10.3389/fimmu.2021.662164.
The Role of Tenascin-C in Tissue Injury and Repair After Stroke.
Okada T, Suzuki H
Front Immunol. 2021; 11:607587.
PMID: 33552066
PMC: 7859104.
DOI: 10.3389/fimmu.2020.607587.
Role of DAMPs and of Leukocytes Infiltration in Ischemic Stroke: Insights from Animal Models and Translation to the Human Disease.
Stanzione R, Forte M, Cotugno M, Bianchi F, Marchitti S, Rubattu S
Cell Mol Neurobiol. 2020; 42(3):545-556.
PMID: 32996044
PMC: 11441194.
DOI: 10.1007/s10571-020-00966-4.
Integrin-mediated adhesive properties of neutrophils are reduced by hyperbaric oxygen therapy in patients with chronic non-healing wound.
Baiula M, Greco R, Ferrazzano L, Caligiana A, Hoxha K, Bandini D
PLoS One. 2020; 15(8):e0237746.
PMID: 32810144
PMC: 7433869.
DOI: 10.1371/journal.pone.0237746.
Predictors of urinary tract infection in acute stroke patients: A cohort study.
Li Y, Xu J, Zhao Y
Medicine (Baltimore). 2020; 99(27):e20952.
PMID: 32629702
PMC: 7337551.
DOI: 10.1097/MD.0000000000020952.
FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells via Activating the AMPK-SIRT1 Signal Pathway.
Zhou B, Qiu Y, Wu N, Chen A, Zhou H, Chen Q
Oxid Med Cell Longev. 2020; 2020:6384803.
PMID: 32509148
PMC: 7254086.
DOI: 10.1155/2020/6384803.